Outcomes of percutaneous coronary intervention (PCI) among patients with connective tissue disease: Propensity match analysis.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 09 10 2019
revised: 04 11 2019
accepted: 27 12 2019
pubmed: 27 1 2020
medline: 15 5 2021
entrez: 27 1 2020
Statut: ppublish

Résumé

Inflammation is the hallmark of coronary artery disease (CAD) and CTD. There are reports of increased prevalence of CAD among patients with CTD such as Rheumatoid Arthritis. However, there is a paucity of data regarding the outcomes of PCI among patients with CTD. Using the National Inpatient Database, patients that underwent PCI between 2007 and 2015 were identified using ICD-9-CM codes. Propensity match analysis with 1: 3 matching of patients with and without CTD was performed. Outcomes were acute kidney injury (AKI), access site complication (ASC), ventricular fibrillation (VF), cardiogenic shock (CS), Stroke, In-hospital mortality and hospital length of stay (LOS) compared between both groups. We identified 17,422 patients with CTD and matched with 52, 266 patients without CTD. Patients were predominantly female (63.1%) and white (77.2%), with a mean age of 63 ± 12.1 years. AKI (8.3% vs. 6.6%, p < 0.001), ASC (3.2% vs. 2.7%, p = 0.01) and hospital stay (4.2 ± 4.8 vs. 3.8 ± 5.2, p < 0.001) were higher among patients with CTD. There was no statistically significant difference in rates of VF, CS, stroke, and In-hospital mortality among the two groups. However, in subgroup analysis, rates of VF were lower among patients with Systemic Lupus Erythematosus (SLE) (1.5% vs. 2.2%, p = 0.006). Patients with CTD undergoing PCI have a higher rate of AKI, Access site complications, and prolonged hospital stay.

Sections du résumé

BACKGROUND
Inflammation is the hallmark of coronary artery disease (CAD) and CTD. There are reports of increased prevalence of CAD among patients with CTD such as Rheumatoid Arthritis. However, there is a paucity of data regarding the outcomes of PCI among patients with CTD.
METHODS
Using the National Inpatient Database, patients that underwent PCI between 2007 and 2015 were identified using ICD-9-CM codes. Propensity match analysis with 1: 3 matching of patients with and without CTD was performed. Outcomes were acute kidney injury (AKI), access site complication (ASC), ventricular fibrillation (VF), cardiogenic shock (CS), Stroke, In-hospital mortality and hospital length of stay (LOS) compared between both groups.
RESULT
We identified 17,422 patients with CTD and matched with 52, 266 patients without CTD. Patients were predominantly female (63.1%) and white (77.2%), with a mean age of 63 ± 12.1 years. AKI (8.3% vs. 6.6%, p < 0.001), ASC (3.2% vs. 2.7%, p = 0.01) and hospital stay (4.2 ± 4.8 vs. 3.8 ± 5.2, p < 0.001) were higher among patients with CTD. There was no statistically significant difference in rates of VF, CS, stroke, and In-hospital mortality among the two groups. However, in subgroup analysis, rates of VF were lower among patients with Systemic Lupus Erythematosus (SLE) (1.5% vs. 2.2%, p = 0.006).
CONCLUSIONS
Patients with CTD undergoing PCI have a higher rate of AKI, Access site complications, and prolonged hospital stay.

Identifiants

pubmed: 31982165
pii: S0167-5273(19)35002-8
doi: 10.1016/j.ijcard.2019.12.055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Informations de copyright

Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no relationships that could be construed as a conflict of interest.

Auteurs

Samson Alliu (S)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA. Electronic address: salliu@maimonidesmed.org.

Justin Ugwu (J)

Department of Cardiology, University of Texas Medical Center, Galveston, TX, USA.

Omotooke Babalola (O)

Department of Internal Medicine, St. Elizabeth Hospital, Youngstown, OH, USA.

Chukwudi Obiagwu (C)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Norbert Moskovits (N)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Sergey Ayzenberg (S)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Gerald Hollander (G)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Robert Frankel (R)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Jacob Shani (J)

Heart and Vascular Institute, Maimonides Medical Center, Brooklyn, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH